PRNP and proteostasis deficiencies: These improved Drosophila models of proteinopathies provided expanded opportunities to identify the intrinsic and extrinsic factors mediating PrP toxicity, including high-throughput genetic screens and targeted amino acid replacements to determine the rules governing PrP toxicity.